2021
- National Medicines Policy Review will be significant for all Australians Friday, 30 July 2021
- Clinical trial national approach will benefit patients and our economy Tuesday, 20 July 2021
- Aboriginal and Torres Strait Islander Medicines Committee launches during NAIDOC Week Wednesday, 7 July 2021
- Moving patient stories highlight opportunities to strengthen our healthcare systems for all Australians Thursday, 24 June 2021
- Prestigious event at Parliament House will ‘make room for the patient view’ Friday, 18 June 2021
- Industry and Health Consumer Organisations working together Monday, 7 June 2021
- CEO initial reactions to 2021 Federal Budget – VIDEO Thursday, 13 May 2021
- 2021-22 FEDERAL BUDGET: Health Front and Centre of Economic Recovery Tuesday, 11 May 2021
- Strategic Agreement Statement – Medicines Australia – The Government and Medicines Australia jointly agree to finalise patient-centric Strategic Agreement after the Budget Saturday, 8 May 2021
- Medicines Australia updated position on Intellectual Property (in light of TRIPS Waiver) Thursday, 6 May 2021
- Medicines Australia position on Intellectual Property (in light of TRIPS Waiver) Friday, 30 April 2021
- Investment in innovative medicines needed to safeguard Australia’s long-term prosperity Sunday, 21 March 2021
- CEO Interview with Sky News Thursday, 18 March 2021
- Medicines Australia welcomes Day 1 of Australia’s vaccination rollout Monday, 22 February 2021
- Medicines Australia’s Statement on Anti-vax Protests Saturday, 20 February 2021
- Medicines Australia’s Statement on the arrival of the Pfizer Vaccine Wednesday, 17 February 2021
- Medicines Australia Statement on TGA’s provisional approval of AstraZeneca’s COVID-19 vaccine Tuesday, 16 February 2021
- Medicines Australia’s position on potential European Union restrictions and vaccines supply Saturday, 30 January 2021